Quotient Sciences Acquires Arcinova

Read the press release here

Arcinova delighted to be finalists in OBN awards!

We have been shortlisted as an OBN awards finalist in the Best CRO category. We are delighted that our outstanding drug development services have been recognised by the OBN awards judges. The prestigious awards ceremony, which celebrates the exceptional work that has been achieved in the Life Sciences, will take place on the 7th November at the Oxford Examination Schools. Find out more here: https://obn-awards.com/award-finalists


Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.